Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Pharmaceutics
|
July 29, 2023
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
Paul Curley, James J Hobson, Neill J Liptrott, et al.
Nanoscale
|
April 22, 2021
Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection
James J Hobson, Alison C Savage, Andrew B Dwyer, et al.
Clinical Pharmacology and Therapeutics
|
May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Usman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
British Journal of Clinical Pharmacology
|
October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
Nanoscale
|
October 24, 2024
Interlaboratory comparison of endotoxin contamination assessment of nanomaterials
Gary Hannon, Bethany J Heaton, Alexander Plant-Hately, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Pharmaceutics
|
July 29, 2023
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
Paul Curley, James J Hobson, Neill J Liptrott, et al.
Nanoscale
|
April 22, 2021
Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection
James J Hobson, Alison C Savage, Andrew B Dwyer, et al.
Clinical Pharmacology and Therapeutics
|
May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Usman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
British Journal of Clinical Pharmacology
|
October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
Nanoscale
|
October 24, 2024
Interlaboratory comparison of endotoxin contamination assessment of nanomaterials
Gary Hannon, Bethany J Heaton, Alexander Plant-Hately, et al.
Page
of 5